NICE: sapropterin now recommended for all pregnant women and young adults with PKU.
In: PharmacoEconomics & Outcomes News, Jg. 886 (2021-09-04), Heft 1, S. 36-36
serialPeriodical
Zugriff:
Until this guidance was announced, only pregnant women with PKU who had uncontrolled PKU through diet alone have been able to access sapropterin on the NHS. Sapropterin [Kuvan; BioMarin] is now recommended as an option for treating phenylketonuria (PKU) in pregnant women until they give birth, as well as for people up to the age of 22 years, in final draft guidance from the UK's National Institute for Health and Care Excellence (NICE). [Extracted from the article]
Titel: |
NICE: sapropterin now recommended for all pregnant women and young adults with PKU.
|
---|---|
Zeitschrift: | PharmacoEconomics & Outcomes News, Jg. 886 (2021-09-04), Heft 1, S. 36-36 |
Veröffentlichung: | 2021 |
Medientyp: | serialPeriodical |
ISSN: | 1173-5503 (print) |
DOI: | 10.1007/s40274-021-08014-3 |
Schlagwort: |
|
Sonstiges: |
|